FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143239617> ?p ?o ?g. }

• W2143239617 endingPage "1687" @default.
• W2143239617 startingPage "1681" @default.
• W2143239617 abstract "Objective: Hypoproteinemia is a common condition in critically ill patients, associated with the development of acute lung injury and acute respiratory distress syndrome and subsequent worse clinical outcomes. Albumin with furosemide benefits lung physiology in hypoproteinemic patients with acute lung injury/acute respiratory distress syndrome, but the independent pharmacologic effects of these drugs are unknown. Design: Randomized, double-blinded, placebo-controlled multicentered trial. Setting: Eleven medical, surgical, and trauma intensive care units including 190 beds within two university hospital systems. Patients: Forty mechanically ventilated patients with acute lung injury/acute respiratory distress syndrome, whose serum total protein concentrations were <6.0 g/dL were included. Patients were excluded for hemodynamic instability or significant renal or hepatic failure. Interventions: Subjects were equally randomly allocated to receive furosemide with albumin or furosemide with placebo for 72 hrs, titrated to fluid loss and normalization of serum total protein concentration. Measurements and Main Results: The primary outcome was change in oxygenation from baseline to day 1, with secondary physiologic and clinical outcomes. There were no differences in baseline characteristics of the subjects in relation to group assignment. Albumin-treated patients had greater increases in oxygenation (mean change in Pao2/Fio2: +43 vs. −24 mm Hg at 24 hrs and +49 vs. −13 mm Hg at day 3), serum total protein (1.5 vs. 0.5 g/dL at day 3), and net fluid loss (−5480 vs. −1490 mL at day 3) throughout the study period (all p < .05). Fluid bolus administration to control patients reduced net negative fluid balance; control patients more frequently developed hypotension and had fewer shock-free days, which translated to differences in organ failure at study end. Conclusions: The addition of albumin to furosemide therapy in hypoproteinemic patients with acute lung injury/acute respiratory distress syndrome significantly improves oxygenation, with greater net negative fluid balance and better maintenance of hemodynamic stability. Additional randomized clinical trials are necessary to examine mechanisms and determine the effect on important clinical outcomes, such as the duration of mechanical ventilation." @default.
• W2143239617 created "2016-06-24" @default.
• W2143239617 creator A5010161670 @default.
• W2143239617 creator A5031081653 @default.
• W2143239617 creator A5052393113 @default.
• W2143239617 creator A5066319415 @default.
• W2143239617 creator A5077888222 @default.
• W2143239617 creator A5091194857 @default.
• W2143239617 date "2005-08-01" @default.
• W2143239617 modified "2023-10-14" @default.
• W2143239617 title "A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury*" @default.
• W2143239617 cites W1978005119 @default.
• W2143239617 cites W1982720179 @default.
• W2143239617 cites W1986485653 @default.
• W2143239617 cites W1986913475 @default.
• W2143239617 cites W1991610484 @default.
• W2143239617 cites W1992098105 @default.
• W2143239617 cites W1994868010 @default.
• W2143239617 cites W1997093722 @default.
• W2143239617 cites W2001334747 @default.
• W2143239617 cites W2005357317 @default.
• W2143239617 cites W2009369296 @default.
• W2143239617 cites W2017920913 @default.
• W2143239617 cites W2019212723 @default.
• W2143239617 cites W2026280600 @default.
• W2143239617 cites W2040476175 @default.
• W2143239617 cites W2041374273 @default.
• W2143239617 cites W2054451736 @default.
• W2143239617 cites W2060419191 @default.
• W2143239617 cites W2061340166 @default.
• W2143239617 cites W2068734467 @default.
• W2143239617 cites W2069642844 @default.
• W2143239617 cites W2070070465 @default.
• W2143239617 cites W2071853044 @default.
• W2143239617 cites W2081317807 @default.
• W2143239617 cites W2090202565 @default.
• W2143239617 cites W2093188926 @default.
• W2143239617 cites W2094764102 @default.
• W2143239617 cites W2095709069 @default.
• W2143239617 cites W2123879397 @default.
• W2143239617 cites W2127258061 @default.
• W2143239617 cites W2140505663 @default.
• W2143239617 cites W2143432233 @default.
• W2143239617 cites W2151578177 @default.
• W2143239617 cites W2161328469 @default.
• W2143239617 cites W2242185212 @default.
• W2143239617 cites W2322673970 @default.
• W2143239617 cites W2597070792 @default.
• W2143239617 cites W2897650666 @default.
• W2143239617 cites W4211218257 @default.
• W2143239617 cites W4293242440 @default.
• W2143239617 cites W4294658238 @default.
• W2143239617 cites W4297819875 @default.
• W2143239617 doi "https://doi.org/10.1097/01.ccm.0000171539.47006.02" @default.
• W2143239617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16096441" @default.
• W2143239617 hasPublicationYear "2005" @default.
• W2143239617 type Work @default.
• W2143239617 sameAs 2143239617 @default.
• W2143239617 citedByCount "292" @default.
• W2143239617 countsByYear W21432396172012 @default.
• W2143239617 countsByYear W21432396172013 @default.
• W2143239617 countsByYear W21432396172014 @default.
• W2143239617 countsByYear W21432396172015 @default.
• W2143239617 countsByYear W21432396172016 @default.
• W2143239617 countsByYear W21432396172017 @default.
• W2143239617 countsByYear W21432396172018 @default.
• W2143239617 countsByYear W21432396172019 @default.
• W2143239617 countsByYear W21432396172020 @default.
• W2143239617 countsByYear W21432396172021 @default.
• W2143239617 countsByYear W21432396172022 @default.
• W2143239617 countsByYear W21432396172023 @default.
• W2143239617 crossrefType "journal-article" @default.
• W2143239617 hasAuthorship W2143239617A5010161670 @default.
• W2143239617 hasAuthorship W2143239617A5031081653 @default.
• W2143239617 hasAuthorship W2143239617A5052393113 @default.
• W2143239617 hasAuthorship W2143239617A5066319415 @default.
• W2143239617 hasAuthorship W2143239617A5077888222 @default.
• W2143239617 hasAuthorship W2143239617A5091194857 @default.
• W2143239617 hasConcept C126322002 @default.
• W2143239617 hasConcept C142724271 @default.
• W2143239617 hasConcept C168563851 @default.
• W2143239617 hasConcept C177713679 @default.
• W2143239617 hasConcept C204787440 @default.
• W2143239617 hasConcept C27081682 @default.
• W2143239617 hasConcept C2777140744 @default.
• W2143239617 hasConcept C2777955127 @default.
• W2143239617 hasConcept C2987404301 @default.
• W2143239617 hasConcept C42219234 @default.
• W2143239617 hasConcept C71924100 @default.
• W2143239617 hasConcept C90924648 @default.
• W2143239617 hasConceptScore W2143239617C126322002 @default.
• W2143239617 hasConceptScore W2143239617C142724271 @default.
• W2143239617 hasConceptScore W2143239617C168563851 @default.
• W2143239617 hasConceptScore W2143239617C177713679 @default.
• W2143239617 hasConceptScore W2143239617C204787440 @default.
• W2143239617 hasConceptScore W2143239617C27081682 @default.
• W2143239617 hasConceptScore W2143239617C2777140744 @default.
• W2143239617 hasConceptScore W2143239617C2777955127 @default.

• next